ArticleLeukemia2026

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Giulia Rappa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.